ORIC position history
The shares of Oric Pharmaceuticals (ORIC) that VIKING GLOBAL INVESTORS LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 4,000,000 shares, $55M, 0.20% of portfolio, New
- 2024 Q2: 4,000,000 shares, $28M, 0.11% of portfolio
- 2024 Q3: 4,000,000 shares, $41M, 0.15% of portfolio
- 2024 Q4: 4,431,008 shares, $36M, 0.12% of portfolio, Add +10.8%
- 2025 Q1: 6,572,700 shares, $37M, 0.12% of portfolio, Add +48.3%
- 2025 Q2: 6,572,700 shares, $67M, 0.19% of portfolio
- 2025 Q3: 6,572,700 shares, $79M, 0.20% of portfolio
- 2025 Q4: 6,572,691 shares, $54M, 0.14% of portfolio, Reduce 0.0%
- 2026 Q1: 5,824,533 shares, $74M, 0.21% of portfolio, Reduce −11.4%
- 2026 Q2: 5,126,762 shares, $56M, 0.16% of portfolio, Reduce −12.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|